Hai Hua Bu
Algemeen Directeur bij Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Actieve functies van Hai Hua Bu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Directeur/Bestuurslid | - | - |
Hepalink (Hong Kong) Co., Ltd. | Directeur/Bestuurslid | - | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - |
Loopbaan van Hai Hua Bu
Eerdere bekende functies van Hai Hua Bu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Directeur/Bestuurslid | 01-12-2006 | 17-04-2021 |
Bedrijfssecretaris | 01-12-2006 | 18-09-2020 |
Opleiding van Hai Hua Bu
Shanghai University of Finance & Economics | Undergraduate Degree |
Shanghai Jiao Tong University | Masters Business Admin |
Statistieken
Internationaal
China | 6 |
Hongkong | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Secretary | 1 |
Undergraduate Degree | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Process Industries | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Chengdu Hepatunn Pharmaceutical Co. Ltd.
Chengdu Hepatunn Pharmaceutical Co. Ltd. Chemicals: Major DiversifiedProcess Industries Part of Pangu Chenchen (Shanghai) Enterprise Management Center LP, Chengdu Hepatunn Pharmaceutical Co. Ltd. manufactures and distributes injections and creams. The company is based in Chengdu, China. Chengdu Hepatunn Pharmaceutical Co. was acquired by Pangu Chenchen (Shanghai) Enterprise Management Center LP from Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on July 14, 2018 for $5.32 million. | Process Industries |
Hepalink (Hong Kong) Co., Ltd. | |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
- Beurs
- Insiders
- Hai Hua Bu
- Ervaring